adenosine has been researched along with Anti-Phospholipid Antibody Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, RA; Bockenstedt, PL; Diaz, JA; Estes, SK; Gandhi, AA; Greve, JM; Kanthi, Y; Knight, JS; Meng, H; Palmer, OR; Pinsky, DJ; Vreede, AP; Yalavarthi, S | 1 |
Alexanderson, E; Amigo, MC; Cruz, P; Goldson, TM; Jara, L; Meave, A; Medina, G; Ricalde, A; Romero-Ibarra, JL; Talayero, JA; Vargas, A; Vera-Lastra, OL | 1 |
2 other study(ies) available for adenosine and Anti-Phospholipid Antibody Syndrome
Article | Year |
---|---|
Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Cyclic AMP; Dipyridamole; Disease Models, Animal; Extracellular Traps; Fibrinolytic Agents; Gene Expression Regulation; Humans; Immunoglobulin G; Male; Mice; Mice, Inbred C57BL; Neutrophils; Phenethylamines; Receptor, Adenosine A2A; Signal Transduction; Vena Cava, Inferior; Venous Thrombosis | 2019 |
Endothelial dysfunction in patients with antiphospholipid syndrome assessed with positron emission tomography.
Topics: Adenosine; Adult; Antiphospholipid Syndrome; Case-Control Studies; Coagulants; Coronary Circulation; Endothelium, Vascular; Female; Heart; Humans; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Prospective Studies | 2007 |